← The Wire
NVAXNasdaq
NOVAVAX INC
Biological Products, (No Diagnostic Substances) · DE · CIK 1000694
Novavax develops vaccines and adjuvants to address global health challenges
$1.46B
Market cap
$9.36
Last close
+5.4%
1D
+4.0%
5D
4.0M
Volume
Price · last 39 sessions+16.6%
May 4L $8.03 · H $11.09Jun 29
344
Total filings
Jun 23, 2026
Last filing
12/31
Fiscal year end
DEFA14ADEFA14AApr 27, 2026DEFA14ADEFA14AApr 30, 2025DEFA14ADEFA14AJun 5, 2024DEFA14ADEFA14AApr 29, 2024DEFA14ADEFA14AJul 7, 2023DEFA14ADEFA14AJun 29, 2023DEFA14ADEFA14AJun 20, 2023DEFA14ADEFA14AJun 15, 2023DEFA14ADEFA14AApr 28, 2023DEFA14ADEFA14AMay 3, 2022DEFA14ADEFA14AMay 27, 2021DEFA14ADEFA14AMay 24, 2021DEFA14ADEFA14AMay 3, 2021DEFA14ADEFA14AJun 18, 2020DEFA14ADEFA14AMay 13, 2020DEFA14ADEFA14AMay 16, 2019DEFA14ADEFA14AApr 30, 2018DEFA14ADEFA14AApr 28, 2017DEFA14ADEFA14AApr 20, 2016DEFA14ADEFA14AApr 30, 2015
In the News
Coverage (30d): 1 reputable article.
Reputable outlets only (Reuters, WSJ, CNBC, Barron's, and peers). More on Google News ↗
Similar companies
Comparable business profile · signals at a glance